TNF and inflammatory bowel disease: In keeping with the heterogeneity of T-cell mediated disease in IBD, robust interventions such as treatment with anti-TNF-α antibodies are not effective in all patients, and patients who initially respond to anti-TNF-α can lose responsiveness over time.